viral
detect
critic
control
diseas
spread
progress
recent
emerg
viral
threat
includ
zika
ebola
current
outbreak
highlight
cost
difficulti
respond
rapidli
address
challeng
develop
platform
lowcost
rapid
detect
viral
rna
dna
nanoswitch
design
mechan
reconfigur
respons
specif
virus
use
zika
viru
model
system
show
nonenzymat
detect
viral
rna
attomol
level
select
multiplex
detect
relat
virus
viral
strain
clinicallevel
sensit
biolog
fluid
pair
assay
sampl
prepar
step
use
either
rna
extract
isotherm
preamplif
assay
perform
minim
lab
infrastructur
readili
adapt
detect
virus
demonstr
adapt
method
quickli
develop
test
dna
nanoswitch
detect
fragment
rna
human
saliva
given
versatil
expect
develop
field
implement
improv
abil
detect
emerg
viral
threat
ultim
limit
impact
biorxiv
preprint
newli
emerg
reemerg
virus
pose
signific
challeng
health
care
system
particularli
global
contribut
rampant
spread
virus
rna
virus
frequent
caus
sweep
outbreak
virus
high
mutat
rate
thu
evolv
rapidli
exampl
includ
annual
influenza
outbreak
ebola
viru
zika
viru
zikv
viru
respons
pandem
technolog
advanc
structur
biolog
genom
import
identifi
virus
advanc
fundament
viral
research
antivir
therapeut
howev
clinic
method
robust
lowcost
rapid
detect
viral
infect
remain
major
challeng
emerg
virus
especi
resourc
limit
area
detect
rna
virus
clinic
set
typic
perform
use
either
immunolog
detect
base
enzymelink
immunosorb
assay
elisa
detect
igm
antibodi
nucleic
acid
test
nat
base
revers
transcript
polymeras
chain
reaction
rtpcr
assay
detect
viral
rna
diagnos
rna
virus
made
challeng
sever
factor
includ
limit
time
window
detect
low
vari
viral
load
crossreact
igm
antibodi
laboratori
resourc
detect
time
window
vari
wide
short
sever
day
long
sever
month
molecular
detect
techniqu
usual
reliabl
perform
within
first
two
week
diseas
depend
time
test
rel
infect
even
highli
sensit
nat
assay
may
still
produc
fals
neg
posit
result
hand
result
igm
serolog
test
often
distinguish
relat
virus
differ
strain
viru
due
crossreact
igm
antibodi
thu
lead
fals
posit
result
detect
challeng
exacerb
outbreak
occur
low
resourc
set
infrastructur
labintens
test
lack
acceler
spread
diseas
respons
challeng
new
techniqu
develop
detect
emerg
virus
among
method
adopt
nanoparticl
crisprbas
method
name
mani
propos
strategi
although
base
cuttingedg
technolog
requir
multipl
reaction
signal
transform
step
address
biosens
challeng
develop
assay
use
programm
dna
nanoswitch
detect
viral
rna
clinic
relev
level
valid
strategi
use
zikv
proofofconcept
system
given
high
global
health
relev
continu
threat
due
reemerg
mosquitoborn
natur
although
zikv
typic
associ
mild
symptom
link
devast
birth
defect
associ
intrauterin
infect
appear
syndrom
adult
possibl
sexual
transmiss
moreov
despit
signific
advanc
understand
ccbync
molecular
biolog
zikv
still
lack
antivir
drug
vaccin
make
robust
detect
zikv
vital
control
spread
diseas
implement
earli
treatment
strategi
detect
presenc
viral
rna
base
use
dna
nanoswitch
design
undergo
conform
chang
linear
loop
upon
bind
target
viral
rna
sequenc
fig
presenc
viral
rna
would
indic
shift
migrat
loop
nanoswitch
gel
electrophoresi
importantli
system
design
use
common
nucleic
acid
stain
nanoswitch
intercal
thousand
dye
molecul
provid
inher
strong
signal
previous
demonstr
sensit
specif
detect
dna
oligonucleotid
microrna
nucleotid
long
use
approach
appli
viral
rna
detect
solv
challeng
detect
long
viral
rna
nucleotid
improv
signal
long
rna
new
signal
multipl
strategi
develop
workflow
measur
viral
load
biolog
mock
clinic
sampl
show
multiplex
use
detect
multipl
ccbyncnd
intern
licens
certifi
peer
review
authorfund
made
avail
copyright
holder
preprint
version
post
januari
http
doi
biorxiv
preprint
virus
simultan
singl
sampl
demonstr
high
specif
even
closelyrel
strain
zika
addit
quick
respons
pandem
develop
dna
nanoswitch
two
day
fig
demonstr
detect
rna
human
saliva
clinic
relev
concentr
approach
nonenzymat
option
combin
isotherm
amplif
step
allow
use
low
resourc
area
fig
work
enabl
direct
detect
viral
rna
without
amplif
pave
way
toward
lowcost
assay
detect
rna
virus
first
proofofconcept
detect
zikv
design
dna
nanoswitch
target
alreadi
valid
sequenc
zikv
genom
use
bind
primer
qpcr
oligo
sequenc
specifi
tabl
made
dna
nanoswitch
hybrid
singlestrand
dna
ssdna
oligo
linear
singlestrand
genom
dna
thermal
anneal
ramp
hour
purifi
highperform
liquid
chromatographi
hplc
initi
detect
target
vitro
transcrib
rna
pflzikv
infecti
plasmid
contain
full
length
genom
cambodia
zikv
isol
fig
previou
result
shown
robust
nanoswitch
detect
small
dna
rna
sequenc
nucleotid
long
viral
rna
expect
strong
secondari
structur
may
interfer
detect
overcom
use
chemic
fragment
method
segment
rna
small
piec
mostli
shorter
nt
fig
fig
incub
nanoswitch
anneal
temperatur
ramp
show
success
detect
fragment
viral
rna
gel
electrophoresi
thu
valid
approach
fig
shown
success
detect
zikv
rna
use
singl
target
sequenc
recogn
could
exploit
larg
genom
size
nucleotid
increas
detect
signal
multipl
target
long
viral
rna
fragment
number
avail
target
sequenc
increas
dramat
sinc
detect
signal
proport
number
loop
nanoswitch
nanoswitch
mixtur
differ
target
sequenc
within
viral
genom
expect
provid
increas
signal
test
develop
algorithm
choos
multipl
sequenc
region
viral
genom
target
nanoswitch
note
first
chose
default
target
length
nucleotid
base
result
screen
nanoswitch
differ
detect
arm
length
fig
algorithm
select
exclud
target
sequenc
could
form
stabl
secondari
structur
fig
crossbind
nanoswitch
backbon
oligo
fig
enforc
gc
content
uniqu
sequenc
base
criteria
chose
target
region
along
entir
zikv
rna
ccbyncnd
intern
licens
certifi
peer
review
authorfund
made
avail
copyright
holder
preprint
version
post
januari
http
doi
biorxiv
preprint
test
design
nanoswitch
facilit
use
matlabbas
softwar
built
graphic
user
interfac
fig
made
freeli
avail
file
valid
qualiti
function
nanoswitch
panel
nanoswitch
nanoswitch
perform
well
molar
excess
posit
dna
control
although
show
signal
variat
fragment
zikv
rna
fig
rank
nanoswitch
strongest
weakest
signal
made
seri
equimolar
nanoswitch
mixtur
use
mixtur
valid
inher
signal
multipl
strategi
use
low
concentr
pool
equimolar
dna
fragment
mimic
fragment
rna
observ
detect
signal
increas
steadili
around
nanoswitch
fig
plateau
valu
plateau
unexpect
consid
largest
mixtur
ad
lower
perform
nanoswitch
may
contribut
less
overal
sampl
sinc
signific
chang
perform
continu
use
nanoswitch
mix
follow
experi
high
sensit
one
key
requir
viral
detect
clinic
level
zikv
rna
bodi
fluid
infect
patient
often
femtomolar
rang
make
amplif
prerequisit
detect
approach
base
earlier
observ
dna
nanoswitch
detect
microrna
nucleotid
subpicomolar
scale
without
amplif
want
assess
sensit
approach
zikv
rna
detect
react
dna
nanoswitch
mixtur
differ
amount
fragment
rna
anneal
temperatur
ramp
result
show
visibl
detect
zikv
rna
low
pg
attomol
fig
fig
reaction
volum
consist
fig
approach
base
use
nanoswitch
mix
outperform
highest
perform
nanoswitch
use
singl
agent
visibl
detect
pg
attomol
fig
anoth
key
requir
clinic
viral
detect
assay
specif
sinc
zikv
dengu
viru
denv
overlap
geograph
distribut
clinic
symptom
infect
either
viru
may
result
clinic
misdiagnosi
serolog
diagnost
assay
known
show
antibodi
crossreact
two
virus
denv
similar
zikv
envelop
protein
genom
sequenc
test
specif
approach
design
similar
panel
nanoswitch
detect
denv
fig
use
pool
nanoswitch
specif
zikv
denv
mix
set
vitro
transcrib
rna
viru
found
perfect
specif
assay
detect
correct
target
rna
fig
use
programm
nanoswitch
demonstr
multiplex
system
simultan
detect
zikv
denv
case
modifi
denv
respons
nanoswitch
form
smaller
loop
size
fig
caus
two
distinct
detect
band
migrat
differ
posit
gel
specif
zikv
rnananoswitch
complex
migrat
slowerhigh
gel
complex
denv
rna
nanoswitch
migrat
fasterlow
gel
fig
therefor
singl
reaction
nanoswitch
show
differenti
specif
detect
zikv
denv
rna
program
differ
loop
size
differ
target
assay
expand
five
viral
target
ccbyncnd
intern
licens
certifi
peer
review
authorfund
made
avail
copyright
holder
preprint
version
post
januari
http
doi
biorxiv
preprint
addit
possibl
misdiagnosi
differ
virus
addit
challeng
determin
specif
strain
viru
exampl
latin
america
four
differ
denv
serotyp
known
present
cocircul
misdiagnosi
infect
strain
signific
implic
treatment
option
thu
abl
accur
identifi
circul
strain
viru
broadli
impact
medic
care
surveil
vector
control
zikv
first
identifi
uganda
spread
asia
america
zikv
strain
classifi
within
african
asian
lineag
share
signific
sequenc
homolog
investig
assay
distinguish
asian
african
lineag
test
nanoswitch
two
zikv
strain
sequenc
homolog
name
isol
cambodia
strain
isol
uganda
design
zikv
strainspecif
nanoswitch
identifi
five
target
region
nucleotid
differ
fig
fig
achiev
better
discern
detect
copyright
holder
preprint
version
post
januari
http
doi
biorxiv
preprint
signal
nanoswitch
uganda
strain
design
form
smaller
loopsiz
design
cambodia
next
human
hepatocellular
carcinoma
cell
line
infect
either
cambodian
ugandan
zikv
strain
infect
cell
process
extract
total
rna
fragment
incub
nanoswitch
probe
viral
rna
either
zikv
cambodia
zikv
uganda
infect
cell
result
show
assay
abl
discrimin
two
strain
viru
even
high
genet
similar
fig
fig
appli
techniqu
detect
zikv
rna
biolog
sampl
either
mockinfect
infect
cell
cambodia
zikv
strain
multipl
infect
extract
rna
zikv
infect
cell
postinfect
nanoswitch
assay
detect
zikv
viral
rna
infect
cell
mock
infect
cell
fig
fig
detect
result
show
copi
zikv
rna
within
infect
cell
steadili
increas
upon
infect
plateau
postinfect
fig
data
demonstr
assay
detect
zikv
rna
infect
cell
line
contrast
typic
rtpcr
assay
without
amplif
viral
rna
move
toward
clinic
applic
aim
demonstr
detect
relev
level
zikv
rna
biolog
fluid
zikv
present
serum
urin
bodi
fluid
infect
patient
viral
load
vari
dramat
individu
bodi
fluid
post
infect
time
frequent
subfemtomolar
femtomolar
rang
zikv
human
urin
report
high
copiesml
fm
nanoswitch
sensit
vitro
transcrib
viral
rna
buffer
approach
clinic
relev
concentr
detect
bodi
fluid
challeng
vari
viral
load
bodi
fluid
reduc
perform
nanoswitch
due
physiolog
condit
nucleas
activ
overcom
potenti
difficulti
investig
two
independ
solut
ad
preprocess
step
extract
rna
bodi
fluid
urin
ad
isotherm
preamplif
step
first
approach
spike
clinicallyrelev
amount
vitro
transcrib
zikv
rna
human
urin
process
viral
rna
extract
use
commerci
rna
extract
kit
mix
extract
rna
nanoswitch
demonstr
nonenzymat
clinic
level
detect
rna
pm
fig
fig
second
approach
demonstr
detect
coupl
amplif
approach
nucleic
acid
sequencebas
amplif
nasba
nasba
combin
multipl
enzym
primer
achiev
rna
amplif
onepot
isotherm
reaction
fig
first
show
feasibl
amplif
zikv
rna
nasba
water
follow
nanoswitch
detect
fig
mimic
clinic
sampl
spike
infecti
zikv
particl
either
pb
human
urin
clinicallevel
fm
fm
sampl
assay
detect
zikv
rna
hour
fig
fig
went
one
step
show
assay
perform
use
commerci
avail
bufferless
gel
cartridg
thermofish
egel
imag
small
potenti
portabl
gel
reader
fig
help
nasba
amplif
detect
abil
method
increas
fm
fig
fm
fig
detect
time
reduc
hour
hour
emerg
outbreak
januari
took
opportun
develop
test
dna
nanoswitch
new
viru
follow
similar
strategi
zikv
identifi
target
region
develop
nanoswitch
use
nasba
strategi
detect
rna
fragment
human
saliva
detect
fragment
concentr
fm
around
clinic
median
fig
compar
rtqpcr
detect
found
similar
detect
level
fig
ccbyncnd
intern
licens
certifi
peer
review
authorfund
made
avail
copyright
holder
preprint
version
post
januari
http
doi
biorxiv
preprint
taken
togeth
demonstr
programm
dna
nanoswitch
develop
robust
viral
rna
detect
platform
readili
adapt
show
detect
platform
key
advantag
exist
methodolog
term
select
specif
shown
experi
zikv
close
relat
denv
well
two
close
relat
zikv
strain
moreov
dna
nanoswitch
viral
rna
detect
strategi
femtomolar
detect
limit
without
rna
amplif
step
attomolar
detect
limit
use
amplif
limit
within
clinic
relev
rang
therefor
dna
nanoswitch
assay
togeth
bufferless
gel
cartridg
present
put
diagnost
assay
clinic
detect
rna
virus
low
resourc
area
without
signific
laboratori
infrastructur
function
dna
nanoswitch
larg
enabl
dna
nanotechnolog
becom
wellestablish
field
use
dna
function
materi
fabric
nanostructur
biosens
particularli
promis
applic
dna
nanotechnolog
reconfigur
dna
devic
demonstr
detect
dna
rna
protein
ph
howev
design
complex
requir
labori
readout
advanc
microscopi
reduc
practic
approach
overcom
practic
hurdl
provid
wide
use
solut
problem
biolog
imag
eg
dnapaint
superresolut
microscopi
dna
scaffold
nmr
cryoem
biosens
eg
detect
lysosom
disord
map
cellular
endocyt
pathway
dna
nanoswitch
take
reductionist
approach
result
assay
robust
sensit
yet
simpl
adapt
requir
multipl
step
expens
equip
work
add
viral
detect
exist
suit
dna
nanoswitch
assay
alreadi
includ
protein
microrna
detect
simpl
dna
nanoswitchbas
assay
detect
viral
rna
overcom
limit
current
avail
method
clinic
detect
rna
virus
resourcelimit
area
challeng
includ
robust
detect
without
enzym
equip
maintain
lowcost
simplic
provid
specif
versatil
surprisingli
current
pandem
shown
us
problem
affect
rich
countri
well
struggl
test
outpac
viral
spread
intrins
high
signal
nanoswitch
enhanc
new
target
multipl
strategi
use
viral
rna
fragment
multipli
number
target
thu
increas
signal
intens
use
approach
reach
nearclin
level
detect
urin
without
use
enzymemedi
amplif
strategi
signific
enzym
key
driver
assay
cost
complex
due
requir
includ
cold
storagetransport
special
buffer
reagent
strict
oper
temperatur
factor
make
enzymat
assay
difficult
field
use
use
low
resourc
area
without
modern
lab
infrastructur
despit
challeng
current
avail
techniqu
reli
enzym
trigger
amplif
assay
demonstr
compat
dramat
signal
improv
option
enzymat
preamplif
step
fig
howev
believ
improv
enabl
complet
coverag
clinic
rang
without
enzym
ml
sampl
urin
zikvinfect
patient
would
contain
copi
viral
rna
theoret
surpass
current
detect
limit
effici
sampl
prepar
use
viral
rna
extract
kit
fig
exampl
could
facilit
use
dna
nanoswitch
assay
ccbyncnd
intern
licens
certifi
peer
review
authorfund
made
avail
copyright
holder
preprint
version
post
januari
http
doi
biorxiv
preprint
two
key
featur
approach
simplic
low
cost
dna
nanoswitch
align
goal
frugal
scienc
movement
cost
access
new
technolog
valu
alongsid
typic
perform
metric
nanoswitch
cost
around
penni
per
reaction
store
dri
room
temperatur
least
month
could
deliv
global
without
transport
biosafeti
concern
assay
consist
step
perform
matter
hour
limit
laboratori
need
fig
assay
use
readout
gel
electrophoresi
rel
inexpens
alreadi
part
workflow
mani
lab
compar
simpler
mani
nanotechnologybas
assay
involv
multipl
incub
wash
step
improv
signal
readout
could
potenti
help
make
approach
even
lab
independ
success
detect
commerci
avail
bufferless
gel
system
fig
take
us
step
closer
enabl
field
deploy
assay
sampl
prepar
could
aid
frugal
scienc
approach
paperfug
lowcost
thermal
cycler
purifi
viral
rna
use
nasba
entir
detect
could
shorten
two
hour
min
nasba
step
hour
nanoswitch
detect
assay
programm
system
make
versatil
wide
varieti
virus
includ
zikv
denv
shown
detect
high
specif
show
zikv
denv
fig
differ
strain
zikv
fig
even
multiplex
fashion
focus
singlestrand
rna
virus
assay
rna
dna
virus
could
like
develop
similarli
fast
construct
purif
process
facilit
rapid
product
dna
nanoswitch
detect
emerg
viral
threat
potenti
littl
day
knowledg
target
sequenc
limit
mostli
oligo
synthesi
turnaround
time
fig
due
low
cost
test
assay
could
also
use
monitor
viral
progress
time
patient
test
potenti
infect
insect
anim
therefor
futur
optim
toward
pointofcar
clinic
applic
resourcelimit
environ
platform
describ
potenti
improv
accuraci
eas
diagnosi
human
nonhuman
vector
anim
ultim
enhanc
abil
control
spread
infect
rapidli
respond
emerg
viral
threat
includ
pandem
work
toward
reduc
death
toll
econom
burden
ccbyncnd
intern
licens
certifi
peer
review
authorfund
made
avail
copyright
holder
preprint
version
post
januari
http
doi
biorxiv
preprint
oligonucleotid
purchas
integr
dna
technolog
idt
standard
desalt
full
sequenc
strand
list
support
inform
tabl
nanoswitch
construct
describ
previous
genom
singlestrand
dna
new
england
biolab
linear
use
target
cleavag
btsci
restrict
enzym
linear
ssdna
mix
molar
excess
oligonucleotid
mixtur
contain
backbon
oligo
detector
anneal
min
thermal
cycler
biorad
usa
follow
construct
nanoswitch
purifi
use
liquid
chromatographi
lc
purif
remov
excess
oligonucleotid
concentr
purifi
nanoswitch
determin
measur
absorb
thermo
scientif
nanodrop
plasmid
contain
fulllength
zikv
cambodia
strain
pflzikv
strain
cdna
gift
dr
peiyong
shi
univers
texa
medic
branch
dr
clair
huang
center
diseas
control
respect
pflzikv
linear
clai
new
england
biolab
neb
linear
xbai
neb
digest
plasmid
extract
phenol
chloroform
isoamyl
alcohol
precipit
linear
plasmid
vitro
transcrib
thermo
fisher
scientif
result
viral
rna
clean
megaclear
transcript
cleanup
kit
thermo
fisher
scientif
follow
protocol
two
kit
except
heat
purif
column
elut
step
viral
rna
notic
high
temperatur
result
degrad
viral
rna
viral
rna
fragment
use
buffer
neb
recommend
protocol
briefli
zikv
rna
obtain
vitro
transcript
mix
fragment
buffer
final
incub
thermal
cycler
min
rna
fragment
analyz
agil
model
use
quantifi
length
distribut
rna
fragment
use
standard
sensit
rna
analysi
kit
fig
total
detect
sampl
volum
mm
nanoswitch
nm
detect
incub
finish
thermal
cycler
thermal
anneal
min
room
temperatur
eg
nasba
relat
detect
load
gel
sampl
stain
gelr
biotium
inc
total
rna
relat
detect
mix
blue
load
dye
experi
fig
fig
first
nanoswitch
purifi
lc
concentr
determin
measur
absorb
thermo
scientif
nanodrop
nanoswitch
mixtur
made
mix
nanoswitch
equimolar
concentr
detect
reaction
volum
nanoswitch
nm
mgcl
block
oligo
nm
block
oligo
short
oligo
nucleotid
prevent
bind
target
rna
inner
surfac
plastic
tube
detect
incub
conduct
thermal
cycler
thermal
anneal
hour
first
ng
total
rna
extract
uninfectedinfect
cell
fragment
minut
fragment
buffer
fragment
total
rna
mix
nanoswitch
nm
mgcl
mm
pb
mixtur
made
nucleasefre
water
sampl
incub
thermal
anneal
ramp
min
incub
sampl
stain
gelr
biotium
inc
concentr
incub
room
temperatur
min
load
gel
blue
load
dye
mix
sampl
sampl
ccbyncnd
intern
licens
certifi
peer
review
authorfund
made
avail
copyright
holder
preprint
version
post
januari
http
doi
biorxiv
preprint
load
well
sampl
run
agaros
gel
v
minut
cold
room
detect
viral
rna
extract
urin
first
spike
zikv
rna
block
oligo
nm
human
urin
mimic
clinic
sampl
use
quickrna
viral
kit
zymo
research
extract
viral
rna
differ
amount
zikv
rna
test
fig
amount
human
urin
scale
need
accord
protocol
kit
final
viral
rna
elut
filter
column
use
nucleasefre
water
extract
rna
fragment
minut
use
fragment
buffer
neb
conduct
nanoswitch
detect
lower
use
fragment
buffer
consider
small
amount
rna
extract
sampl
notic
much
fragment
buffer
could
destroy
dna
nanoswitch
data
shown
first
employ
classic
nasba
protocol
prove
concept
fig
copyright
holder
preprint
version
post
januari
http
doi
biorxiv
preprint
contain
enzym
cocktail
nec
buffer
ntp
mix
mm
dntp
mix
mm
two
primer
mix
um
rnase
inhibitor
uul
neb
murin
sampl
viral
rna
sampl
incub
hour
thermal
cycler
follow
heat
minut
deactiv
enzym
nasba
sampl
use
follow
dna
nanoswitch
detect
assay
pcr
tube
final
volum
assay
finish
incub
room
temperatur
two
hour
mix
gelr
biotium
inc
blue
load
dye
detect
sampl
load
ml
agaros
gel
run
tbe
buffer
v
room
temperatur
minut
gblock
gene
fragment
rna
segment
purchas
idt
tabl
pcr
amplif
qiagen
taq
pcr
core
kit
use
creat
copi
promot
ad
end
forward
primer
afterword
dsdna
templat
clean
qiaquick
pcr
purif
kit
qiagen
final
rna
obtain
vitro
transcript
neb
high
yield
rna
synthesi
kit
clean
megaclear
transcript
cleanup
kit
thermo
fisher
scientif
rtpcr
detect
conduct
use
luna
univers
onestep
rtqpcr
kit
neb
follow
protocol
ul
rna
sampl
use
ul
reaction
mix
detect
sampl
run
agaros
gel
unless
otherwis
note
cast
molecular
biolog
grade
agaros
fisher
bioreag
dissolv
tbe
buffer
typic
run
condit
v
minut
room
temperatur
cold
room
sampl
mix
ficol
base
blue
load
dye
prior
load
imag
complet
biorad
gel
doc
xr
imag
differ
exposur
time
base
bright
detect
band
detect
effici
analyz
use
includ
imag
lab
softwar
fig
profil
detect
band
obtain
imagej
integr
intens
obtain
use
peak
analysi
function
origin
originlab
corpor
data
present
fig
detail
analysi
procedur
found
previou
public
egel
relat
experi
use
invitrogen
egel
agaros
system
thermo
fisher
scientif
precast
agaros
gel
sybr
stain
nanoswitch
detect
sampl
load
lane
gel
run
volt
hour
room
temperatur
sinc
egel
system
allow
user
control
voltag
use
extern
power
supplier
connect
neg
posit
electrod
precast
agaros
gel
suppli
volt
ccbyncnd
intern
licens
certifi
peer
review
authorfund
made
avail
copyright
holder
preprint
version
post
januari
http
doi
biorxiv
preprint
